<?xml version="1.0" encoding="UTF-8"?>
<!DOCTYPE article PUBLIC "-//TaxonX//DTD Taxonomic Treatment Publishing DTD v0 20100105//EN" "../../nlm/tax-treatment-NS0.dtd">
<article xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:tp="http://www.plazi.org/taxpub" article-type="research-article" dtd-version="3.0" xml:lang="en">
  <front>
    <journal-meta>
      <journal-id journal-id-type="publisher-id">97</journal-id>
      <journal-id journal-id-type="index">urn:lsid:arphahub.com:pub:B5033382-9D21-53CE-B630-B4E3A1146D51</journal-id>
      <journal-title-group>
        <journal-title xml:lang="en">Bulgarian Cardiology</journal-title>
        <abbrev-journal-title xml:lang="en">Bulgarian Cardiology</abbrev-journal-title>
      </journal-title-group>
      <issn pub-type="ppub">1310-7488</issn>
      <issn pub-type="epub">2683-1015</issn>
      <publisher>
        <publisher-name>Bulgarian Society of Cardiology</publisher-name>
      </publisher>
    </journal-meta>
    <article-meta>
      <article-id pub-id-type="doi">10.3897/bgcardio.27.e64020</article-id>
      <article-id pub-id-type="publisher-id">64020</article-id>
      <article-categories>
        <subj-group subj-group-type="heading">
          <subject>Review Article</subject>
        </subj-group>
        <subj-group subj-group-type="scientific_subject">
          <subject>Epidemiology and Prevention (епидемиология и превенция)</subject>
        </subj-group>
      </article-categories>
      <title-group>
        <article-title>Specific diagnosis of SARS-CoV-2</article-title>
      </title-group>
      <contrib-group content-type="authors">
        <contrib contrib-type="author" corresp="yes">
          <name name-style="western">
            <surname>Argirova</surname>
            <given-names>Radka</given-names>
          </name>
          <email xlink:type="simple">radkaargirova@abv.bg</email>
          <xref ref-type="aff" rid="A1">1</xref>
        </contrib>
        <contrib contrib-type="author" corresp="no">
          <name name-style="western">
            <surname>Koleva</surname>
            <given-names>Vesselina</given-names>
          </name>
          <xref ref-type="aff" rid="A1">1</xref>
        </contrib>
      </contrib-group>
      <aff id="A1">
        <label>1</label>
        <addr-line content-type="verbatim">Acibadem City Clinic Tokuda Hospital and Medical Center, Clinical Laboratory, Sofia, Bulgaria</addr-line>
        <institution>Acibadem City Clinic Tokuda Hospital and Medical Center, Clinical Laboratory</institution>
        <addr-line content-type="city">Sofia</addr-line>
        <country>Bulgaria</country>
      </aff>
      <author-notes>
        <fn fn-type="corresp">
          <p>Corresponding author: Radka Argirova (<email xlink:type="simple">radkaargirova@abv.bg</email>).</p>
        </fn>
        <fn fn-type="edited-by">
          <p>Academic editor: Nina Gotcheva</p>
        </fn>
      </author-notes>
      <pub-date pub-type="collection">
        <year>2021</year>
      </pub-date>
      <pub-date pub-type="epub">
        <day>07</day>
        <month>04</month>
        <year>2021</year>
      </pub-date>
      <volume>27</volume>
      <issue>1</issue>
      <fpage>12</fpage>
      <lpage>21</lpage>
      <uri content-type="arpha" xlink:href="http://openbiodiv.net/73E00812-F821-54A0-A9AC-C08BADC9D822">73E00812-F821-54A0-A9AC-C08BADC9D822</uri>
      <history>
        <date date-type="received">
          <day/>
          <month/>
          <year/>
        </date>
      </history>
      <permissions>
        <copyright-statement>Radka Argirova, Vesselina Koleva</copyright-statement>
        <license license-type="creative-commons-attribution" xlink:href="http://creativecommons.org/licenses/by/4.0/" xlink:type="simple">
          <license-p>This is an open access article distributed under the terms of the Creative Commons Attribution License (CC BY 4.0), which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited.</license-p>
        </license>
      </permissions>
      <abstract>
        <label>Abstract</label>
        <p>Rapid and precise diagnosis of the causative virus SARS-CoV-2 under COVID-19 pandemic conditions is essential for the control of infection in both asymptomatic viral carriers and individuals with signs of the disease. Diagnostic tests allow identiﬁ cation of contact persons, timely starting of treatment, possibilities for assessing progress of disease. They are the basis for important decisions aiming minimizing of the virus spread in the society, especially when effective therapy and appropriate vaccines are lacking. In this review, we summarize the two main groups of diagnostic tests – molecular and serologic ones – a subject of permanent evolving and improvement. Special attention is paid to different factors during performance of the tests as types of samples, intended use of every test and its correct interpretation.</p>
      </abstract>
    </article-meta>
  </front>
</article>
